Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines

BACKGROUND: The newly registered adjuvanted herpes zoster subunit vaccine (HZ/su) has a higher efficacy than the available live-attenuated vaccine (ZVL). National decision-makers soon need to decide whether to introduce HZ/su or to prefer HZ/su above ZVL. METHODS: Using a Markov model with a decisio...

Descripción completa

Detalles Bibliográficos
Autores principales: de Boer, Pieter T., van Lier, Alies, de Melker, Hester, van Wijck, Albert J. M., Wilschut, Jan C., van Hoek, Albert Jan, Postma, Maarten J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282315/
https://www.ncbi.nlm.nih.gov/pubmed/30518427
http://dx.doi.org/10.1186/s12916-018-1213-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282315/
https://www.ncbi.nlm.nih.gov/pubmed/30518427
http://dx.doi.org/10.1186/s12916-018-1213-5

Ejemplares similares